Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Anika Therapeutics, Inc. (ANIK)

30.34   -0.11 (-0.36%) 11-25 13:00
Open: 30.67 Pre. Close: 30.45
High: 30.92 Low: 30.08
Volume: 16,177 Market Cap: 443(M)

Technical analysis

as of: 2022-11-25 1:55:08 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 37.97     One year: 44.35
Support: Support1: 27.64    Support2: 24.63
Resistance: Resistance1: 32.5    Resistance2: 37.97
Pivot: 30.29
Moving Average: MA(5): 30.47     MA(20): 30.02
MA(100): 24.82     MA(250): 26.59
MACD: MACD(12,26): 1.1     Signal(9): 1.3
Stochastic oscillator: %K(14,3): 63.8     %D(3): 63.6
RSI: RSI(14): 57.6
52-week: High: 41.18  Low: 19.95
Average Vol(K): 3-Month: 92 (K)  10-Days: 74 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ ANIK ] has closed below upper band by 49.0%. Bollinger Bands are 46.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 22 days. This is a sign that the current trend might continue.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 31.38 - 31.54 31.54 - 31.66
Low: 29.95 - 30.16 30.16 - 30.33
Close: 30.16 - 30.47 30.47 - 30.73

Company Description

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.

Headline News

Thu, 24 Nov 2022
Meet Anik Gupta, the young football fanatic ready for the spotlight - The Chatham News + Record

Fri, 18 Nov 2022
Quinta Brunson Gushes About Her Husband Not Trying To ‘Dim’ Her Light - MadameNoire

Thu, 17 Nov 2022
"They would just start f**king railing on her" - Jon Anik addresses UFC 281 crowd that booed Carla Esparza every time she came on the mic - Sportskeeda

Thu, 17 Nov 2022
Quinta Brunson on her husband, representation, and 'Abbott Elementary' - Insider

Thu, 17 Nov 2022
Jon Anik recaps Alex Pereira’s late finish of Israel Adesanya, UFC 281, remembers Anthony Johnson - MMA Fighting

Sat, 12 Nov 2022
Fans appreciate "GOAT of Everything" Jon Anik after the commentator's thorough explanation of how to pronounce Alex Pereira - Sportskeeda

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 15 (M)
Shares Float 13 (M)
% Held by Insiders 1.9 (%)
% Held by Institutions 93.4 (%)
Shares Short 987 (K)
Shares Short P.Month 990 (K)

Stock Financials

EPS -0.12
EPS Est Next Qtl 0.36
EPS Est This Year 2.04
EPS Est Next Year 1.92
Book Value (p.s.) 19.51
Profit Margin (%) -10.4
Operating Margin (%) -11.7
Return on Assets (ttm) -3.2
Return on Equity (ttm) -5.5
Qtrly Rev. Growth 1.7
Gross Profit (p.s.) 6.28
Sales Per Share 10.43
EBITDA (p.s.) -0.22
Qtrly Earnings Growth 0
Operating Cash Flow 8 (M)
Levered Free Cash Flow 3 (M)

Stock Valuations

PE Ratio -252.84
PEG Ratio -3.3
Price to Book value 1.55
Price to Sales 2.9
Price to Cash Flow 52.76

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.